Fetal Cardiac Intervention for Pulmonary Atresia with Intact Ventricular Septum: International Fetal Cardiac Intervention Registry.

Congenital heart defect Fetal cardiac intervention Fetal echocardiography Pulmonary atresia with intact ventricular septum Valvuloplasty

Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
07 Jul 2020
Historique:
received: 12 02 2020
accepted: 19 04 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 8 7 2020
Statut: aheadofprint

Résumé

Invasive fetal cardiac intervention (FCI) for pulmonary atresia with intact ventricular septum (PAIVS) and critical pulmonary stenosis (PS) has been performed with small single-institution series reporting technical and physiological success. We present the first multicenter experience. Describe fetal and maternal characteristics of those being evaluated for FCI, including pregnancy/neonatal outcome data using the International Fetal Cardiac Intervention Registry (IFCIR). We queried the IFCIR for PAIVS/PS cases evaluated from January 2001 to April 2018 and reviewed maternal/fetal characteristics, procedural details, pregnancy and neonatal outcomes. Data were analyzed using standard descriptive statistics. Of the 84 maternal/fetal dyads in the registry, 58 underwent pulmonary valvuloplasty at a median gestational age of 26.1 (21.9-31.0) weeks. Characteristics of fetuses undergoing FCI varied in terms of tricuspid valve (TV) size, TV regurgitation, and pulmonary valve patency. There were fetal complications in 55% of cases, including 7 deaths and 2 delayed fetal losses. Among those who underwent successful FCI, the absolute measurement of the TV increased by 0.32 (±0.17) mm/week from intervention to birth. Among 60 liveborn with known outcome, there was a higher percentage having a biventricular circulation following successful FCI (87 vs. 43%). Our data suggest a possible benefit to fetal therapy for PAIVS/PS, though rates of technically unsuccessful procedures and procedure-related complications, including fetal loss were substantial. FCI criteria are extremely variable, making direct comparison to nonintervention patients challenging and potentially biased. More uniform FCI criteria for fetuses with PAIVS/PS are needed to avoid unnecessary procedures, expose only fetuses most likely to sustain a benefit, and to enable comparisons to be made with nonintervention patients.

Identifiants

pubmed: 32634804
pii: 000508045
doi: 10.1159/000508045
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Subventions

Organisme : Department of Health
ID : II-LA-0716-20001
Pays : United Kingdom

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Whitnee J Hogan (WJ)

University of California-San Francisco, San Francisco, California, USA, whitnee.hogan@ucsf.edu.

Sofia Grinenco (S)

Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Aimee Armstrong (A)

Nationwide Children's Hospital, Columbus, Ohio, USA.

Roland Devlieger (R)

Department of Obstetrics and Gynaecology, University Hospitals KU Leuven, Leuven, Belgium.

Joanna Dangel (J)

Department of Perinatal Cardiology and Congenital Anomalies, Centre of Postgraduate Medical Education, Warsaw, Poland.

Queralt Ferrer (Q)

Vall d'Hebron Hospital, Barcelona, Spain.

Michele Frommelt (M)

Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA.

Alberto Galindo (A)

Hospital Universitario, Universidad Complutense de Madrid, Madrid, Spain.

Helena Gardiner (H)

The Fetal Center at Children's Memorial Hermann Hospital, Houston, Texas, USA.

Sarah Gelehrter (S)

C. S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA.

Ulrike Herberg (U)

University of Bonn, Bonn, Germany.

Lisa Howley (L)

Children's Hospital Colorado, Aurora, Colorado, USA.

Edgar Jaeggi (E)

Hospital for Sick Children, Toronto, Ontario, Canada.

Joana Miranda (J)

Centro Hospitalar São João, Porto, Portugal.

Shaine A Morris (SA)

Baylor College of Medicine, Houston, Texas, USA.

Dick Oepkes (D)

Leiden University Medical Center, Leiden, The Netherlands.

Simone Pedra (S)

Hospital do Coração, São Paulo, Brazil.

Renuka Peterson (R)

Saint Louis University, St Louis, Missouri, USA.

Gary Sholler (G)

Heart Center for Children, Children's Hospital at Westmead and University of Sydney, Sydney, New South Wales, Australia.

John Simpson (J)

Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust Hospitals, London, United Kingdom.

James Strainic (J)

Rainbow Babies and Children's Hospital Division of Pediatric Cardiology, University Hospitals, Cleveland, Ohio, USA.

Trisha V Vigneswarran (TV)

Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust Hospitals, London, United Kingdom.

Annette Wacker-Gussmann (A)

German Heart Center, Department of Pediatric Cardiology and Adult Congenital Heart Disease, Munich, Germany.

Anita J Moon-Grady (AJ)

University of California-San Francisco, San Francisco, California, USA.

Classifications MeSH